Novo Nordisk's Wegovy faces supply constraints as demand surges
Novo Nordisk said lower-dose strengths of Wegovy will be limited as it tries to ramp up production to meet the surge in demand for the weight loss drug.
Hims & Hers CEO Andrew Dudum launches weight management program
Hims & Hers Health CEO and co-founder Andrew Dudum discusses the telehealth company's weight loss platform on 'The Claman Countdown.'
Novo Nordisk weight loss drug Wegovy cuts heart disease risk by 20%, trial shows
Novo Nordisk said the results of a late-stage drug trial showed weight loss drug Wegovy also can cut the risk of heart disease in certain patients.
Eli Lilly diabetes medication drives nearly $1 billion in sales as demand persists
Eli Lilly reported strong second quarter sales Tuesday in large part because of the demand for its diabetes treatment Mounjaro. The drug might also be game-changer for obesity.
Alzheimer's drug Leqembi could roll out to certain US health care systems in next few months
Health care systems around the U.S. are planning to start rolling out Alzheimer's drug Leqembi to qualifying patients. Some hospitals will start within the next month or two.
Biogen to cut 1,000 jobs as focus turns to Alzheimer's drug Leqembi launch
Biogen said on Tuesday it expects to eliminate roughly 1,000 positions in the U.S. to save money ahead of launching a new drug to treat Alzheimer's disease.
Vaccines are not a threat to the public: Doctor Bob Lahita
St. Joseph’s Institute for Autoimmune Diseases director Dr. Bob Lahita argues Democratic presidential candidate Robert F. Kennedy Jr. is spreading misinformation and disinformation on vaccines on ‘Cavuto: Coast to Coast.’
Apple's Tim Cook is a 'great operator,' he will keep delivering: John Sculley
Former Apple CEO John Sculley discusses how Tim Cook can grow Apple's $3 trillion market cap and Tesla's Cybertruck projections on 'The Claman Countdown.'
AI should not be replacing any kind of physician: Dr. Marc Siegel
Fox News medical contributor Dr. Marc Siegel joined ‘The Big Money Show’ to discuss artificial intelligence and its controversial impact on the medical community.
Dr. Elisa Port breaks down breast cancer myths on ‘Mornings with Maria’
Mount Sinai Chief of Breast Surgery Dr. Elisa Port joins ‘Mornings with Maria’ to debunk breast cancer myths in an effort to raise awareness for women nationwide.
Apple stole our technology, employees: Masimo CEO Joe Kiani
Masimo CEO Joe Kiani discusses his patent battle with Apple over smartwatch trade secrets on 'The Claman Countdown.'
EU health officials investigate weight loss drugs after reports of suicidal thoughts
Health officials in the European Union are investigating some popular weight loss drugs after three cases of patients reported having self-harming or suicidal thoughts.
Rep. Buddy Carter: 'Pharmaceutical independence is important to national security'
Rep. Buddy Carter, R-Ga., discusses the 'Made in America Act,' decoupling from China and Bill Gates' meeting Chinese President Xi Jinping.
Death toll rises in fungal meningitis outbreak tied to procedures in Mexico
The Centers for Disease Control and Prevention (CDC) is investigating a multinational outbreak of fungal meningitis that has already killed four people.
Studies show Ozempic, Wegovy have a 'very positive' effect on the brain: Dr. Marc Siegel
Fox News medical contributor Dr. Marc Siegel discusses whether weight loss drugs like Ozempic can lower anxiety and depression on 'Varney & Co.'
AstraZeneca's Tagrisso increases survival rate in some post-surgery lung cancer patients
David Fredrickson, Executive V.P. of the oncology business at AstraZeneca, discusses Tagrisso decreasing lung caner risk by 51%.
Millions of Americans cutting costs by cutting prescriptions
The CDC reports 9 million Americans are not taking their medications as prescribed as costs surge. Fox News' Steve Harrigan reports on the risks.
Breakthrough cancer treatment is not something insurance will cover: Dr. Marc Siegel
Fox News medical contributor Dr. Marc Siegel joined ‘Mornings with Maria’ to discuss the Israeli cancer treatment that is reporting a 90% success rate.
Nvidia's shares are 'mind boggling': Al Root
Ben Levisohn, Al Root and Carleton English discuss the markets following a tech stock rally, surging Nvidia shares and the impact on the pharmaceutical market from weight loss drugs.
Teva's Richard Francis launches 'pivot to growth' strategy
Teva Pharmaceuticals CEO Richard Francis outlines his roadmap to accelerate growth on 'The Claman Countdown.'